ESR1 and neoplasm: Our analysis showed a tendency toward HR-negative/HER2-positive and ER-positive/PR-negative/HER2-negative subtypes and a trend away from the HR-positive/HER2-negative and triple-positive subtypes from the primary tumor to the BCBM (Figure 3B).